ARROWHEAD PHARMACEUTICALS, INC. Net Income (Loss) Attributable to Noncontrolling Interest
ARROWHEAD PHARMACEUTICALS, INC. (ARWR) reported Net Income (Loss) Attributable to Noncontrolling Interest of $15.36 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Income Statement › Net Income
us-gaap:NetIncomeLossAttributableToNoncontrollingInterest · last filed 2026-08-04
- ARROWHEAD PHARMACEUTICALS, INC. net income (loss) attributable to noncontrolling interest for the quarter ending 2026-06-30 was $15.36M.
- ARROWHEAD PHARMACEUTICALS, INC. net income (loss) attributable to noncontrolling interest for the quarter ending 2026-03-31 was -$4.84M.
- ARROWHEAD PHARMACEUTICALS, INC. net income (loss) attributable to noncontrolling interest for the quarter ending 2025-12-31 was -$2.57M.
- ARROWHEAD PHARMACEUTICALS, INC. net income (loss) attributable to noncontrolling interest for the quarter ending 2025-09-30 was $39.87M.
- ARROWHEAD PHARMACEUTICALS, INC. net income (loss) attributable to noncontrolling interest for fiscal 2025 was $31.75M.
- ARROWHEAD PHARMACEUTICALS, INC. net income (loss) attributable to noncontrolling interest for fiscal 2024 was -$10.20M.
- ARROWHEAD PHARMACEUTICALS, INC. net income (loss) attributable to noncontrolling interest for fiscal 2023 was -$4.00M.
- ARROWHEAD PHARMACEUTICALS, INC. net income (loss) attributable to noncontrolling interest for fiscal 2022 was -$431.00K.
| Period end | Net Income (Loss) Attributable to Noncontrolling Interest 3 month | Net Income (Loss) Attributable to Noncontrolling Interest 6 month | Net Income (Loss) Attributable to Noncontrolling Interest 9 month | Net Income (Loss) Attributable to Noncontrolling Interest 12 month | Net Income (Loss) Attributable to Noncontrolling Interest 98 month | Net Income (Loss) Attributable to Noncontrolling Interest 101 month | Net Income (Loss) Attributable to Noncontrolling Interest 104 month | Net Income (Loss) Attributable to Noncontrolling Interest 107 month | Net Income (Loss) Attributable to Noncontrolling Interest 110 month | Net Income (Loss) Attributable to Noncontrolling Interest 113 month | Net Income (Loss) Attributable to Noncontrolling Interest 116 month | Net Income (Loss) Attributable to Noncontrolling Interest 119 month | Net Income (Loss) Attributable to Noncontrolling Interest 122 month | Net Income (Loss) Attributable to Noncontrolling Interest 125 month | Net Income (Loss) Attributable to Noncontrolling Interest 128 month | Net Income (Loss) Attributable to Noncontrolling Interest 131 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $15.36M 10-Q · filed 2026-08-04 | $10.52M derived: sum of 2 quarters · filed 2026-08-04 | $7.96M 10-Q · filed 2026-08-04 | $47.83M derived: sum of 4 quarters · filed 2026-08-04 | ||||||||||||
| 2026-03-31 | -$4.84M 10-Q · filed 2026-05-07 | -$7.41M 10-Q · filed 2026-05-07 | $32.46M derived: sum of 3 quarters · filed 2026-05-07 | $29.05M derived: sum of 4 quarters · filed 2026-08-04 | ||||||||||||
| 2025-12-31 | -$2.57M 10-Q · filed 2026-02-05 | $37.30M derived: sum of 2 quarters · filed 2026-02-05 | $33.89M derived: sum of 3 quarters · filed 2026-08-04 | $31.31M derived: sum of 4 quarters · filed 2026-08-04 | ||||||||||||
| 2025-09-30 | $39.87M derived: 10-K 12 month − 10-Q 9 month · filed 2025-11-25 | $36.46M derived: sum of 2 quarters · filed 2026-08-04 | $33.88M derived: sum of 3 quarters · filed 2026-08-04 | $31.75M 10-K · filed 2025-11-25 | ||||||||||||
| 2025-06-30 | -$3.41M 10-Q · filed 2026-08-04 | -$5.99M derived: sum of 2 quarters · filed 2026-08-04 | -$8.13M 10-Q · filed 2026-08-04 | -$10.93M derived: sum of 4 quarters · filed 2026-08-04 | ||||||||||||
| 2025-03-31 | -$2.58M 10-Q · filed 2026-05-07 | -$4.71M 10-Q · filed 2026-05-07 | -$7.52M derived: sum of 3 quarters · filed 2026-05-07 | -$10.71M derived: sum of 4 quarters · filed 2026-05-07 | ||||||||||||
| 2024-12-31 | -$2.13M 10-Q · filed 2026-02-05 | -$4.94M derived: sum of 2 quarters · filed 2026-02-05 | -$8.13M derived: sum of 3 quarters · filed 2026-02-05 | -$9.82M derived: sum of 4 quarters · filed 2026-02-05 | ||||||||||||
| 2024-09-30 | -$2.81M derived: 10-K 12 month − 10-Q 9 month · filed 2025-11-25 | -$5.99M derived: sum of 2 quarters · filed 2025-11-25 | -$7.69M derived: sum of 3 quarters · filed 2025-11-25 | -$10.20M 10-K · filed 2025-11-25 | ||||||||||||
| 2024-06-30 | -$3.18M 10-Q · filed 2025-08-07 | -$4.88M derived: sum of 2 quarters · filed 2025-08-07 | -$7.39M 10-Q · filed 2025-08-07 | -$8.73M derived: sum of 4 quarters · filed 2025-11-25 | ||||||||||||
| 2024-03-31 | -$1.70M 10-Q · filed 2025-05-12 | -$4.21M 10-Q · filed 2025-05-12 | -$5.54M derived: sum of 3 quarters · filed 2025-11-25 | -$6.72M derived: sum of 4 quarters · filed 2025-11-25 | ||||||||||||
| 2023-12-31 | -$2.51M 10-Q · filed 2025-02-10 | -$3.85M derived: sum of 2 quarters · filed 2025-11-25 | -$5.03M derived: sum of 3 quarters · filed 2025-11-25 | -$6.03M derived: sum of 4 quarters · filed 2025-11-25 | ||||||||||||
| 2023-09-30 | -$1.34M derived: 10-K 12 month − 10-Q 9 month · filed 2025-11-25 | -$2.52M derived: sum of 2 quarters · filed 2025-11-25 | -$3.51M derived: sum of 3 quarters · filed 2025-11-25 | -$4.00M 10-K · filed 2025-11-25 | ||||||||||||
| 2023-06-30 | -$1.18M 10-Q · filed 2024-08-08 | -$2.18M derived: sum of 2 quarters · filed 2024-08-08 | -$2.66M 10-Q · filed 2024-08-08 | -$3.10M derived: sum of 4 quarters · filed 2024-11-26 | ||||||||||||
| 2023-03-31 | -$999.00K 10-Q · filed 2024-05-09 | -$1.49M 10-Q · filed 2024-05-09 | -$1.92M derived: sum of 3 quarters · filed 2024-11-26 | -$1.92M derived: sum of 4 quarters · filed 2024-11-26 | ||||||||||||
| 2022-12-31 | -$486.00K 10-Q · filed 2024-02-06 | -$917.00K derived: sum of 2 quarters · filed 2024-11-26 | -$917.00K derived: sum of 3 quarters · filed 2024-11-26 | -$917.00K derived: sum of 4 quarters · filed 2024-11-26 | ||||||||||||
| 2022-09-30 | -$431.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-11-26 | -$431.00K derived: sum of 2 quarters · filed 2024-11-26 | -$431.00K derived: sum of 3 quarters · filed 2024-11-26 | -$431.00K 10-K · filed 2024-11-26 | ||||||||||||
| 2022-06-30 | $0.00 10-Q · filed 2023-08-07 | $0.00 derived: sum of 2 quarters · filed 2023-08-07 | $0.00 10-Q · filed 2023-08-07 | |||||||||||||
| 2022-03-31 | $0.00 10-Q · filed 2023-05-02 | $0.00 10-Q · filed 2023-05-02 | ||||||||||||||
| 2021-12-31 | $0.00 10-Q · filed 2023-02-06 | |||||||||||||||
| 2021-09-30 | $0.00 10-K · filed 2023-11-29 | |||||||||||||||
| 2020-09-30 | $0.00 10-K · filed 2022-11-28 | |||||||||||||||
| 2014-09-30 | -$90.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-12-14 | $2.38K derived: sum of 2 quarters · filed 2016-12-14 | -$37.80K derived: sum of 3 quarters · filed 2016-12-14 | -$95.22K 10-K · filed 2016-12-14 | ||||||||||||
| 2014-06-30 | $2.47K 10-Q · filed 2015-08-04 | -$37.71K derived: sum of 2 quarters · filed 2015-08-04 | -$95.13K 10-Q · filed 2015-08-04 | -$208.01K derived: sum of 4 quarters · filed 2015-12-14 | ||||||||||||
| 2014-03-31 | -$40.18K 10-Q · filed 2015-05-11 | -$97.60K 10-Q · filed 2015-05-11 | -$210.47K derived: sum of 3 quarters · filed 2015-12-14 | -$309.09K derived: sum of 4 quarters · filed 2015-12-14 | -$19.48M 10-Q · filed 2014-05-06 | |||||||||||
| 2013-12-31 | -$57.42K 10-Q · filed 2015-02-09 | -$170.30K derived: sum of 2 quarters · filed 2015-12-14 | -$268.91K derived: sum of 3 quarters · filed 2015-12-14 | -$451.00K derived: sum of 4 quarters · filed 2015-12-14 | -$19.44M 10-Q · filed 2014-02-04 | |||||||||||
| 2013-09-30 | -$112.88K derived: 10-K 12 month − 10-Q 9 month · filed 2015-12-14 | -$211.49K derived: sum of 2 quarters · filed 2015-12-14 | -$393.58K derived: sum of 3 quarters · filed 2015-12-14 | -$560.14K 10-K · filed 2015-12-14 | -$19.38M 10-K · filed 2013-12-18 | |||||||||||
| 2013-06-30 | -$98.62K 10-Q · filed 2014-08-12 | -$280.70K derived: sum of 2 quarters · filed 2014-08-12 | -$447.27K 10-Q · filed 2014-08-12 | -$734.34K derived: sum of 4 quarters · filed 2014-11-25 | -$19.27M 10-Q · filed 2013-08-07 | |||||||||||
| 2013-03-31 | -$182.08K 10-Q · filed 2014-05-06 | -$348.65K 10-Q · filed 2014-05-06 | -$635.72K derived: sum of 3 quarters · filed 2014-11-25 | -$883.27K derived: sum of 4 quarters · filed 2014-11-25 | -$19.17M 10-Q · filed 2013-05-09 | |||||||||||
| 2012-12-31 | -$166.57K 10-Q · filed 2014-02-04 | -$453.64K derived: sum of 2 quarters · filed 2014-11-25 | -$701.19K derived: sum of 3 quarters · filed 2014-11-25 | -$950.07K derived: sum of 4 quarters · filed 2014-11-25 | -$18.99M 10-Q · filed 2013-02-13 | |||||||||||
| 2012-09-30 | -$287.07K derived: 10-K 12 month − 10-Q 9 month · filed 2014-11-25 | -$534.62K derived: sum of 2 quarters · filed 2014-11-25 | -$783.50K derived: sum of 3 quarters · filed 2014-11-25 | -$984.79K 10-K · filed 2014-11-25 | -$18.82M 10-K · filed 2012-12-28 | |||||||||||
| 2012-06-30 | -$247.55K 10-Q · filed 2013-08-07 | -$496.43K derived: sum of 2 quarters · filed 2013-08-07 | -$697.73K 10-Q · filed 2013-08-07 | -$868.14K derived: sum of 4 quarters · filed 2013-08-07 | -$18.53M 10-Q · filed 2012-08-13 | |||||||||||
| 2012-03-31 | -$248.88K 10-Q · filed 2013-05-09 | -$450.18K 10-Q · filed 2013-05-09 | -$620.59K derived: sum of 3 quarters · filed 2013-05-09 | -$814.09K derived: sum of 4 quarters · filed 2013-05-09 | -$18.28M 10-Q · filed 2012-05-08 | |||||||||||
| 2011-12-31 | -$201.29K 10-Q · filed 2013-02-13 | -$371.71K derived: sum of 2 quarters · filed 2013-02-13 | -$565.21K derived: sum of 3 quarters · filed 2013-02-13 | -$771.06K derived: sum of 4 quarters · filed 2013-02-13 | -$18.04M 10-Q · filed 2012-02-09 | |||||||||||
| 2011-09-30 | -$170.41K derived: 10-K 12 month − 10-Q 9 month · filed 2012-12-28 | -$363.91K derived: sum of 2 quarters · filed 2012-12-28 | -$569.77K derived: sum of 3 quarters · filed 2012-12-28 | -$363.51K 10-K · filed 2012-12-28 | -$17.83M 10-Q · filed 2012-08-13 | |||||||||||
| 2011-06-30 | -$193.50K 10-Q · filed 2012-08-13 | -$399.35K derived: sum of 2 quarters · filed 2012-08-13 | -$193.10K 10-Q · filed 2012-08-13 | -$503.21K derived: sum of 4 quarters · filed 2012-08-13 | -$17.66M 10-Q · filed 2011-08-08 | |||||||||||
| 2011-03-31 | -$205.85K 10-Q · filed 2012-05-08 | $398.00 10-Q · filed 2012-05-08 | -$309.71K derived: sum of 3 quarters · filed 2012-05-08 | -$622.45K derived: sum of 4 quarters · filed 2012-05-08 | ||||||||||||
| 2010-12-31 | $206.25K 10-Q · filed 2012-02-09 | -$103.86K derived: sum of 2 quarters · filed 2012-02-09 | -$416.60K derived: sum of 3 quarters · filed 2012-02-09 | |||||||||||||
| 2010-09-30 | -$310.11K derived: 10-K 12 month − 10-Q 9 month · filed 2011-12-20 | -$622.85K derived: sum of 2 quarters · filed 2011-12-20 | -$1.18M 10-K · filed 2011-12-20 | |||||||||||||
| 2010-06-30 | -$312.74K 10-Q · filed 2011-08-08 | -$872.88K 10-Q · filed 2011-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 |